Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An important feature of the development of many human and animal tumours is the appearance of pre-malignant benign lesions, some of which undergo further changes during progression to malignancy. Many of the currently accepted concepts of multi-stage carcinogenesis have been developed using an experimental model based on the chemical induction of tumours in mouse skin. In this system, many of the premalignant papillomas which arise are promoter-dependent, and appear to regress if promoter treatment is interrupted, whereas others progress to form autonomous benign lesions and, in some cases, malignant carcinomas. Although the number and nature of the events leading to malignancy are not known, DNA transfection experiments have led to the identification of several genes which may be qualitatively altered in tumour cells (see ref. 6 for review). We have previously shown that DNA from transplantable mouse skin carcinomas induced by chemical carcinogens has the ability to transform NIH/3T3 cells, and that the gene responsible for the transformation is an activated form of the mouse cellular Harvey-ras gene (c-rasH). We have now investigated the stage of carcinogenesis at which the proto-oncogene acquires transforming activity. We demonstrate that primary papillomas induced by chemical carcinogens in two different mouse strains have an activated c-rasH gene. This constitutes the first report of a benign tumour which contains DNA with detectable transforming activity. In addition, steady-state levels of c-rasH gene transcripts are elevated in the papillomas as compared with normal epidermis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these G4 TERCÀ/À APC min mice exhibited a profound suppression of more advanced adenomatous lesions in association with significant intratumoral growth arrest and apoptosis (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Quantitative analysis of mice with multiple intestinal neoplasia (min) provided further evidence that telomere shortening can dramatically impair tumor development in epithelial cells at specific stages in the malignant transformation process.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“In this APC min model, the addition of telomere dysfunction resulted in an increase in early neoplastic lesions probably due to chromosome instability resulting in increased loss of the remaining wild-type APC allele.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“The antitumor effects of telomere dysfunction resulted in dramatically increased survival in G4 TERCÀ/À APC min mice by preventing blood loss caused by gastrointestinal tract adenomas.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Anaphase bridges, a hallmark of dysfunctional telomeres, are low in adenomas but increase substantially at the adenoma-carcinoma transition.Anaphase bridges become significantly more abundant at the pre-invasive and invasive colon cancer stages (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
Citations
Cites
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,086
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
The Function and Mechanism of Promoters of Carcinogenesis
Boutwell, R. K., & Sivak, A. (1973) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447309025704 · Cited by 746
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Cooper, G. M. (1982) · Science · doi:10.1126/science.6285471 · Cited by 606
A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer
Armitage, P., & Doll, R. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.22 · Cited by 555
Oncogenes in solid human tumours
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 478
Research works printed but not linked: 4
- Pierce, G. B. & Fennell, R. H. in Cancer Medicine (eds Holland, J. F. & Frei, E.) 149–167 (Lea & Febiger, Philadelphia, 1982).
- Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W. (eds) Carcinogenesis Vol. 7 (Raven, New York, 1982).
- Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
- Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
Cited by
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
“For example, mouse mammary and skin tumours that were induced by the topical application of carcinogens contained H- Ras mutation”
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Su, F., Viros, A., Milagre, C., Trunzer, K., Bollag, G., Spleiss, O., Reis-Filho, J. S., Kong, X., Koya, R. C., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105358 · Cited by 1,038
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F. (1984) · Nature · doi:10.1038/311029a0 · Cited by 989
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859
Self-citationHeat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., & Barbacid, M. (1985) · Nature · doi:10.1038/315382a0 · Cited by 820
Hunter, T. (1991) · Cell · doi:10.1016/0092-8674(91)90637-e · Cited by 767
THE MOLECULAR GENETICS OF CELLULAR ONCOGENES
Varmus, H. E. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.003005 · Cited by 756
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., Sansom, O. J., Zender, L., & Keyes, W. M. (2017) · Genes & Development · doi:10.1101/gad.290635.116 · Cited by 650
Multistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
Abel, E. L., Angel, J. M., Kiguchi, K., & DiGiovanni, J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.120 · Cited by 563
Samuel, M. S., Lopez, J. I., McGhee, E. J., Croft, D. R., Strachan, D., Timpson, P., Munro, J., Schröder, E., Zhou, J., Brunton, V. G., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.008 · Cited by 541
Mechanisms of carcinogenesis induced by alkylating agents
SAFFHILL, R., MARGISON, G., & OCONNOR, P. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(85)90009-5 · Cited by 456
Kemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
Self-citationMalignant transformation of early passage rodent cells by a single mutated human oncogene
Spandidos, D. A., & Wilkie, N. M. (1984) · Nature · doi:10.1038/310469a0 · Cited by 457
RAF inhibitors that evade paradoxical MAPK pathway activation
Zhang, C., Spevak, W., Zhang, Y., Burton, E. A., Ma, Y., Habets, G., Zhang, J., Lin, J., Ewing, T., Matusow, B., et al. (2015) · Nature · doi:10.1038/nature14982 · Cited by 382
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
Self-citationGonzález‐Suárez, E., Samper, E., Ramírez, A., Flores, J. M., Martín‐Caballero, J., Jorcano, J. L., & Blasco, M. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2619 · Cited by 372
Farr, C. J., Saiki, R. K., Erlich, H. A., McCormick, F., & Marshall, C. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1629 · Cited by 356
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A. (2000) · Nature Genetics · doi:10.1038/79089 · Cited by 347
You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., & Anderson, M. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3070 · Cited by 336
50 Years of Preclinical Anticancer Drug Screening: Empirical to Target-Driven Approaches
Suggitt, M., & Bibby, M. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.971.11.3 · Cited by 298
Leder, A., Kuo, A., Cardiff, R. D., Sinn, E., & Leder, P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9178 · Cited by 293
Inhibitory effects of Nigella sativa and saffron (crocus sativus) on chemical carcinogenesis in mice
Salomi, M. J., Nair, S. C., & Panikkar, K. R. (1991) · Nutrition and Cancer · doi:10.1080/01635589109514142 · Cited by 283
BRAF targeted therapy changes the treatment paradigm in melanoma
Ribas, A., & Flaherty, K. T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.69 · Cited by 271
Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., & Balmain, A. (1990) · Cell · doi:10.1016/0092-8674(90)90115-u · Cited by 277
Self-citationStem-cell hierarchy in skin cancer
Perez-Losada, J., & Balmain, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1095 · Cited by 268
Self-citationBrown, K., Buchmann, A., & Balmain, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.2.538 · Cited by 272
Self-citationGuasch, G., Schober, M., Pasolli, H. A., Conn, E. B., Polak, L., & Fuchs, E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.020 · Cited by 268
Activated Oncogenes in B6C3F1 Mouse Liver Tumors: Implications for Risk Assessment
Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., & Anderson, M. W. (1987) · Science · doi:10.1126/science.3629242 · Cited by 275
Deciphering the cells of origin of squamous cell carcinomas
Sánchez-Danés, A., & Blanpain, C. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0024-5 · Cited by 261
Chemical Carcinogenesis: From Animal Models To Molecular Models In One Decade
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60434-0 · Cited by 267
Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis
Akhurst, R. J., Fee, F., & Balmaint, A. (1988) · Nature · doi:10.1038/331363a0 · Cited by 272
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D., & Brinster, R. L. (1987) · Cell · doi:10.1016/0092-8674(87)90710-0 · Cited by 262
Activation of ras Oncogenes Preceding the Onset of Neoplasia
Kumar, R., Sukumar, S., & Barbacid, M. (1990) · Science · doi:10.1126/science.2188364 · Cited by 258
Matrisian, L. M., Bowden, G. T., Krieg, P., Fürstenberger, G., Briand, J. P., Leroy, P., & Breathnach, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9413 · Cited by 255
Self-citationWiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W., & Miller, J. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5825 · Cited by 250
Brown, K., Quintanilla, M., Ramsden, M., Kerr, I. B., Young, S., & Balmain, A. (1986) · Cell · doi:10.1016/0092-8674(86)90665-3 · Cited by 245
Self-citationMutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.
Bizub, D., Wood, A. W., & Skalka, A. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6048 · Cited by 229
Differential expression of the ras gene family in mice.
Leon, J., Guerrero, I., & Pellicer, A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.4.1535 · Cited by 222
Janssen, J. W., Steenvoorden, A. C., Lyons, J., Anger, B., Böhlke, J. U., Bos, J. L., Seliger, H., & Bartram, C. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9228 · Cited by 225
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue
Roop, D. R., Lowy, D. R., Tambourin, P. E., Strickland, J., Harper, J. R., Balaschak, M., Spangler, E. F., & Yuspa, S. H. (1986) · Nature · doi:10.1038/323822a0 · Cited by 215
Glick, A. B., Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C., O'Reilly, M., Sporn, M. B., Karlsson, S., & Yuspa, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6076 · Cited by 207
New Classes of Tumor Promoters: Teleocidin, Aplysiatoxin, and Palytoxin
(1987) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60799-x · Cited by 206
von Karstedt, S., Conti, A., Nobis, M., Montinaro, A., Hartwig, T., Lemke, J., Legler, K., Annewanter, F., Campbell, A. D., Taraborrelli, L., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.014 · Cited by 196
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Paolo Dotto, G., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 204
Kraus, M. H., Yuasa, Y., & Aaronson, S. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5384 · Cited by 201
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
Artandi, S. E., & Attardi, L. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.211 · Cited by 191
Enhanced expression of the c‐myc protooncogene in high‐grade human prostate cancers
Buttyan, R., Sawczuk, I. S., Benson, M. C., Siegal, J. D., & Olsson, C. A. (1987) · The Prostate · doi:10.1002/pros.2990110405 · Cited by 191
Transformation of Human Bronchial Epithelial Cells Transfected by Harvey ras Oncogene
Yoakum, G. H., Lechner, J. F., Gabrielson, E. W., Korba, B. E., Malan-Shibley, L., Willey, J. C., Valerio, M. G., Shamsuddin, A. M., Trump, B. F., & Harris, C. C. (1985) · Science · doi:10.1126/science.3975607 · Cited by 192
Ras proteins in the control of the cell cycle and cell differentiation
Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000645 · Cited by 189
Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma
Nassar, D., Latil, M., Boeckx, B., Lambrechts, D., & Blanpain, C. (2015) · Nature Medicine · doi:10.1038/nm.3878 · Cited by 189
Functions of the aryl hydrocarbon receptor in the skin
Esser, C., Bargen, I., Weighardt, H., Haarmann-Stemmann, T., & Krutmann, J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0394-4 · Cited by 187
Spandidos, D. A., & Kerr, I. B. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.108 · Cited by 188
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel
Yuan, S., Almagro, J., & Fuchs, E. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00660-9 · Cited by 169
Grand, R. J. A., & Owen, D. (1991) · Biochemical Journal · doi:10.1042/bj2790609 · Cited by 181
Reynolds, S. H., Stowers, S. J., Maronpot, R. R., Anderson, M. W., & Aaronson, S. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.33 · Cited by 175
Activated Proto-onc Genes: Sufficient or Necessary for Cancer?
Duesberg, P. H. (1985) · Science · doi:10.1126/science.3992240 · Cited by 179
Stimulation of angiogenesis by Ras proteins
Kranenburg, O., Gebbink, M. F. B. G., & Voest, E. E. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.09.004 · Cited by 168
Muschel, R. J., Williams, J. E., Lowy, D. R., & Liotta, L. A. (1985) · PubMed · Cited by 175
Franza, B. R., Maruyama, K., Garrels, J. I., & Ruley, H. E. (1986) · Cell · doi:10.1016/0092-8674(86)90462-9 · Cited by 166
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R., & Owens, D. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205588 · Cited by 165
Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck
Field, J. K. (1992) · European Journal of Cancer Part B: Oral Oncology · doi:10.1016/0964-1955(92)90016-t · Cited by 162
Carcinogenesis in mouse and human cells: parallels and paradoxes
Balmain, A., & C.Harris, C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.371 · Cited by 155
Self-citationOncogenic regulation and function of keratins 8 and 18
Oshima, R. G., Baribault, H., & Caul�n, C. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00054012 · Cited by 156
Reddig, P. J., Dreckschmidt, N. E., Ahrens, H., Simsiman, R. C., Tseng, C. P., Zou, J., Oberley, T. D., & Verma, A. K. (1999) · PubMed · Cited by 154
Human cancer and cellular oncogenes
Nishimura, S., & Sekiya, T. (1987) · Biochemical Journal · doi:10.1042/bj2430313 · Cited by 163
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
Glick, A. B., Lee, M. M., Darwiche, N., Kulkarni, A. B., Karlsson, S., & Yuspa, S. H. (1994) · Genes & Development · doi:10.1101/gad.8.20.2429 · Cited by 157
Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma
Modi, B. G., Neustadter, J., Binda, E., Lewis, J., Filler, R. B., Roberts, S. J., Kwong, B. Y., Reddy, S., Overton, J. D., Galan, A., et al. (2012) · Science · doi:10.1126/science.1211600 · Cited by 148
Marshall, C. J., Vousden, K. H., & Phillips, D. H. (1984) · Nature · doi:10.1038/310586a0 · Cited by 151
Müller‐Decker, K., Scholz, K., Marks, F., & Fürstenberger, G. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120106 · Cited by 147
CD34 Expression by Hair Follicle Stem Cells Is Required for Skin Tumor Development in Mice
Trempus, C. S., Morris, R. J., Ehinger, M., Elmore, A., Bortner, C. D., Ito, M., Cotsarelis, G., Nijhof, J. G. W., Peckham, J., Flagler, N. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3128 · Cited by 147
Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis.
Yaswen, P., Goyette, M., Shank, P. R., & Fausto, N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.4.780 · Cited by 138
Dotto, G. P., Weinberg, R. A., & Ariza, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6389 · Cited by 139
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis
Blanco, R., Muñoz, P., Flores, J. M., Klatt, P., & Blasco, M. A. (2007) · Genes & Development · doi:10.1101/gad.406207 · Cited by 135
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
Hirakawa, T., & Ruley, H. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1519 · Cited by 133
Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis
伊勢, 和., Nakamura, K., Nakao, K., Shimizu, S., Harada, H., Ichise, T., Miyoshi, J., Gondo, Y., Ishikawa, T., Aiba, A., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203600 · Cited by 132
Wei, G., Ku, S., Gene, K. A., Saito, S., Tang, A. A., Zhang, J., Mao, J., Appella, E., Balmain, A., & Huang, E. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703213104 · Cited by 143
Self-citationInhibition of Protein Kinase B (PKB) and PKCζ Mediates Keratin K10-Induced Cell Cycle Arrest
Paramio, J. M., Segrelles, C., Ruiz, S., & Jorcano, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7449-7459.2001 · Cited by 128
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures
Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Balmain, A., Portella, G., Fusco, A., & Goodwin, G. H. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90352-2 · Cited by 127
Self-citationVousden, K. H., Bos, J. L., Marshall, C. J., & Phillips, D. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1222 · Cited by 127
K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
Cerny, W. L., Mangold, K. A., & Scarpelli, D. G. (1992) · PubMed · Cited by 123
Leptak, C., Ramon y Cajal, S., Kulke, R., Horwitz, B. H., Riese, D. J., Dotto, G. P., & DiMaio, D. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.7078-7083.1991 · Cited by 99
Aldaz, C. M., Conti, C. J., Klein–Szanto, A. J., & Slaga, T. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2029 · Cited by 120
Nelson, M. A., Futscher, B. W., Kinsella, T., Wymer, J. A., & Bowden, G. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6398 · Cited by 117
Self-citationTennenbaum, T., Weiner, A. K., Belanger, A. J., Glick, A. B., Hennings, H., & Yuspa, S. H. (1993) · PubMed · Cited by 115
Mutational activation of oncogenes in animal model systems of carcinogenesis (MTR 07217)
Guerrero, I., & Pellicer, À. (1987) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(87)90021-2 · Cited by 121
Craig, A. M., Bowden, G. T., Chambers, A. F., Spearman, M. A., Greenberg, A. H., Wright, J., McLeod, M. R., & Denhardt, D. T. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460124 · Cited by 118
Self-citationDandekar, S., Sukumar, S. V., Zarbl, H., Young, L. J. T., & Cardiff, R. D. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.4104-4108.1986 · Cited by 112
Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa
Tremain, R., Marko, M. G., Vijayachandra, K., Ueno, H., Böttinger, E. P., & Glick, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203471 · Cited by 112
Dlugosz, A. A., Mischak, H., Mushinski, J. F., & Yuspa, S. H. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940050409 · Cited by 107
Stromelysin in tumor progression and metastasis
Donnell, S. M., & Matrisian, L. M. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00049521 · Cited by 107
Vassar, R. J., Hutton, M. E., & Fuchs, E. V. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4643-4653.1992 · Cited by 106
Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells
Paterson, H., Reeves, B. R., Brown, R., Hall, A., Furth, M. E., Bos, J. L., Jones, P., & Marshall, C. J. (1987) · Cell · doi:10.1016/0092-8674(87)90103-6 · Cited by 105
Transforming ras oncogenes and multistage carcinogenesis
Balmain, A. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.1 · Cited by 105
Self-citationNischt, R., Roop, D. R., Mehrel, T., Yuspa, S. H., Rentrop, M., Winter, H., & Schweizer, J. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010205 · Cited by 111
Metadata
- Authors
- Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- ORCID
- Balmain, Allan
- Venue
- Nature
- Published
- 1984-02
- Volume
- 307
- Issue
- 5952
- Pages
- 658-660
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015936619
- Cited by
- 529
- References
- 19
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 16 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- skin papilloma, chemical carcinogenesis, precancerous lesions, proto-oncogene activation, transforming activity, gene expression, epidermis
- MeSH terms
- Proto-Oncogene Mas, Animals, Cell Transformation, Neoplastic, Gene Expression Regulation, Oncogenes, Papilloma, Skin Neoplasms, Transcription, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.